Azitra (AZTR) Other Working Capital Changes (2022 - 2026)
Azitra (AZTR) posted Other Working Capital Changes of -$76649.0 for Q1 2026, down 1.14% on a QoQ basis from -$75782.0 in Q4 2025, and up 1.64% year-over-year from -$75413.2 in Q1 2025.
Azitra (AZTR) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Azitra's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$76649.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 1.64% year-over-year to -$76649.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$303636.0 (up 3.86% YoY) and the FY2025 annual result came in at -$304913.0, up 3.46% from the prior year.
- Other Working Capital Changes was -$76649.0 for Q1 2026 at Azitra, down from -$75782.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $40012.0 in Q3 2022 and bottomed at -$40541.0 in Q4 2022.
- A 5-year average of -$57.71 and a median of -$54.5 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes slipped 20.4% — and 2025, when it rose 9.84%.
- Azitra's Other Working Capital Changes stood at -$65656.0 in 2022, then fell by 6.34% to -$69817.0 in 2023, then retreated by 20.4% to -$84057.0 in 2024, then rose by 9.84% to -$75782.0 in 2025, then decreased by 1.14% to -$76649.0 in 2026.
- Business Quant data shows AZTR's Other Working Capital Changes at -$76649.0 in Q1 2026, -$75782.0 in Q4 2025, and -$74948.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76,649.00 |
| Mar 31, 2026 | -76,649.00 |
| Mar 31, 2026 | -76,649.00 |
| Dec 31, 2025 | -75,782.00 |
| Dec 31, 2025 | -75,782.00 |
| Dec 31, 2025 | -75,782.00 |
| Sep 30, 2025 | -74,948.00 |
| Sep 30, 2025 | -74,948.00 |
| Sep 30, 2025 | -74,948.00 |
| Jun 30, 2025 | -76,257.00 |
| Jun 30, 2025 | -76,257.00 |
| Jun 30, 2025 | -76,257.00 |
| Mar 31, 2025 | -77,926.00 |
| Mar 31, 2025 | -77,926.00 |
| Mar 31, 2025 | -77,926.00 |
| Dec 31, 2024 | -84,057.00 |
| Dec 31, 2024 | -84,057.00 |
| Dec 31, 2024 | -84,057.00 |
| Sep 30, 2024 | -75,618.00 |
| Sep 30, 2024 | -75,618.00 |